ABSTRACT-The effects of stable strontium were investigated in ovariectomized (OVX) rats by calcium balance and calcium kinetic studies, histomorphometric analysis and measurements of calcium levels in bone. After 10 days of pair-feeding with a control diet, 71-day-old female Wistar rats were either shamoperated (Sham group) or ovariectomized. The OVX rats were divided into two subgroups: those that were treated with strontium (OVX+Sr group, strontium intake; 87.5 ymol/day/rat) and those that were not (OVX group). Both groups were pair-fed their respective control or strontium diets for 2 weeks. Calcein and tetracycline were injected every 2 weeks from 1 week before ovariectomy to calculate the rate of bone formation in the diaphyseal femora cortex (°1o BFFC). In the OVX group, urinary calcium and % BFFC decreased, while bone resorption, bone formation and femora length increased at the end of the experiment, as compared with those in the Sham group. No such changes were observed in rats in the OVX+Sr group. The calcium balance, calcium levels in bone and trabecular bone volume in the metaphysis did not change in any of the three groups. These results suggest that strontium may be able to prevent the changes in bone turnover induced by estrogen deficiency.
Keywords:Calcium, Strontium, Bone formation, Bone resorption, OvariectomyOvariectomized (OVX) animal models in a variety of species have been used to evaluate the mechanism of or to assess the effect of drugs in estrogen deficiency (1 -4). Although several histomorphometric studies have been performed to investigate the mechanism of estrogen deficiency, only a few have also studied calcium metabolism. Indeed, changes in calcium metabolism are closely associated with, or induce, morphometric disorders in OVX animals. Thus, the analysis of calcium metabolism in OVX rats is necessary to evaluate the mechanism of estrogen deficiency, and calcium balance and calcium kinetic studies are useful for investigating it (5). Our previous report showed that a large amount of strontium, more than approx. 400 mg/kg/day, disturbs calcium metabolism in intact rats and produces inhibitory effects on calcium metabolism, such as decreased intestinal calcium absorption, decreased bone formation and resorption, negative calcium balance, and decreased calcium contents in bone (6, 7). On the other hand, a strontium-containing substance (S12911) has been shown to prevent femoral osteopenia in OVX rats (8). Morphometrically, the effects of this substance can be observed within 60 days after ovariectomy, at dosages that correspond to less than approx. 100 mg/kg/day of strontium (8). It has been considered that low-dose strontium has a beneficial effect in OVX animals. However, there are few reports on calcium metabolism that investigate the effects of lowdose strontium in OVX rats. Wronski et al. (9) demonstrated that changes in histomorphometric parameters can be detected as early as 14 days after ovariectomy by measuring the percent of cancellous bone volume in tibiae. We hypothesized...